Synthesis and hydrolytic properties of polyphosphazene/(diamine)platinum/saccharide conjugates

Journal of Controlled Release

Volumn 55, Issue 2-3, 1998, Pages 161-170

  Song, Soo Chang ^a   Sohn, Youn Soo ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

Anticancer drug; Controlled release; Polymer drug conjugates; Polyphosphazene (diamine)platinum saccharide conjugates; Targeting drug

Indexed keywords

ANTINEOPLASTIC AGENT; ORGANOPHOSPHORUS COMPOUND; PLATINUM;

ARTICLE; CONJUGATE; CONTROLLED STUDY; DEGRADATION; DRUG TARGETING; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

CARBOHYDRATES; CHROMATOGRAPHY, GEL; HYDROLYSIS; ORGANOPHOSPHORUS COMPOUNDS; ORGANOPLATINUM COMPOUNDS; POLYMERS; SPECTRUM ANALYSIS;

EID: 0009674418     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(98)00046-7     Document Type: Article

References (20)

1. A.G. Sicopelianos, Polyphosphazenes as new biomaterials, in: S.W. Shalaby (Ed.), Biomedical Polymers, Hanser/Gardner Publications, Cincinnati, Ohio, 1994, pp. 153-171.
2. S.K. Carter, Cisplatin past, present and future, in: M.P. Hacker, E.B. Double, I.H. Krakoff (Eds.), Platinum Coordination Complexes in Cancer Chemotherapy, Martinus Nijhoff Publishing, Boston, 1984, pp. 359-376.
3. J.R. Duran, A clinical overview, in: A.W. Prestayko, S.T. Crooke, S.K. Carter (Eds.), Cisplatin Current Status and New Developments, Academic Press, New York, 1980, pp. 317-321.
4. P.J. Loehrer, L.H. Einhorn, Drugs five years later, cisplatin, Ann. Intern. Med. 100 (1984) 704-713.
5. R.F. Ozols, R.C. Young, Chemotherpy of ovarian cancer, Semin. Oncol. 11 (1984) 251-263.
6. W.-S. Hong, N. Saijo, Y. Sasaki, K. Minato, H. Nakano, K. Nakagawa, Y. Fugiwara, K. Nomura, P.R. Twentyman, Establishment and characterization of cisplatin-resistant sublines of human lung cancer lines, Int. J. Cancer 41 (1988) 462-467.
7. H. Maeda, L.W. Seymour, Y. Miyamoto, Conjugates of anticancer agents and polymers: Advantages of Macromolecular therapeutics in vivo, Bioconjugate Chem. 3(5) (1992) 351-362.
8. H. Maeda, Y Matsumura, Tumoritropic and lymphotropic principles of macromolecular drugs, Crit. Rev. Ther. Drug Carrier Syst. 6(3) (1989) 193-210.
9. B. Schechter, A. Neumann, M. Wilchek, R. Arnon, Soluble polymers as carriers of cis-platinum, J. Contr. Rel. 10 (1989) 75-87.
10. M. Yokoyama, T. Okano, Y. Sakurai, S. Suwa, K. Kataoka, Introduction of cisplatin into polymeric micelle, J. Contr. Rel. 39 (1996) 351-356.
11. Y.S. Sohn, H.-G. Baek, Y.H. Cho, Y.A. Lee, O.-S. Jung, C.O. Lee, Y.S. Kim, Synthesis and antitumor activity of novel polyphosphazene-(diamine)platinum(II) conjugates, Int. J. Pharmaceutics 153 (1997) 79-91.
12. R.C. Harrison, C.A. McAuliffe, A.M. Zaki, An effects route for the preparation of highly soluble platinum(II) anticancer agents, Inorg. Chim. Acta 46 (1980) 15-16.
13. Y.S. Sohn, Y.H. Cho, H.-G. Baek, O.-S. Jung, Synthesis and properties of low molecular weight polyphosphazenes, Macromolecules 28 (1995) 7566-7568.
14. K. Kobayashi, H. Sumitomo, Y Ina, Synthesis and functions of polystyrene derivatives having pendant oligosaccharides, Polymer J. 17(4) (1985) 567-575.
15. J.P. Greenstein and M. Winitz, Chemistry of the amino acid, John Wiley and Sons, Inc., New York, London, Sydney, 1961.
16. J.R. Vaughan, J. Am. Chem. Soc. 73 (1951) 3547-3550.
17. H.R. Allcock, S.R. Pucher, M.L. Turner, R.J. Fitzpartrick, Poly(organophosphazenes) with poly(alkyl ether) side groups: A study of their water solubility and the swelling characteristics of their hydrogels, Macromolecules 25 (1992) 5573-5577.
18. H.R. Allcock, Phosphorus-Nitrogen compounds, Academic Press, New York and London, 1972.
19. N.L. Jrinick, J. Kopeček, Soluble polymers as targetable drug carriers, in: R.L. Juliano (Ed.), Targeted drug delivery, Springer-Verlag, Berlin, Heidelberg, 1991, pp. 105-166.
20. D. Putnam, J. Kopeček, Polymer conjugates with an anti-cancer activity, in: Advances in polymer science, Vol. 122, Springer-Verlag, Berlin, Heidelberg, 1995, pp. 55-123.